Subcutaneous omalizumab for people with asthma
Donovan T., Milan SJ., Adatia A., Solkar Z., Stovold E., Dwan K., Hinks TSC., Crossingham I.
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children.